368 related articles for article (PubMed ID: 12554904)
1. Pharmacotherapy and airway remodelling in asthma?
Beckett PA; Howarth PH
Thorax; 2003 Feb; 58(2):163-74. PubMed ID: 12554904
[TBL] [Abstract][Full Text] [Related]
2. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
3. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL
Adv Ther; 2008 Apr; 25(4):342-54. PubMed ID: 18421428
[TBL] [Abstract][Full Text] [Related]
4. [Alternations of bronchial smooth muscle and effect of therapy on remodeling in asthma].
Pałgan K; Dziedziczko A; Bartuzi Z
Pol Merkur Lekarski; 2006 Jul; 21(121):5-7. PubMed ID: 17007282
[TBL] [Abstract][Full Text] [Related]
5. Airway wall remodelling: the influence of corticosteroids.
Ward C; Walters H
Curr Opin Allergy Clin Immunol; 2005 Feb; 5(1):43-8. PubMed ID: 15643343
[TBL] [Abstract][Full Text] [Related]
6. Inhaled steroids and airway remodelling in asthma.
Chetta A; Marangio E; Olivieri D
Acta Biomed; 2003 Dec; 74(3):121-5. PubMed ID: 15055015
[TBL] [Abstract][Full Text] [Related]
7. Asthma therapy: effects on airway inflammation and remodelling.
Boulet LP
Can Respir J; 1998; 5(1):68-70. PubMed ID: 9556518
[No Abstract] [Full Text] [Related]
8. Remodeling in asthma and chronic obstructive lung disease.
Jeffery PK
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S28-38. PubMed ID: 11734464
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic interventions aimed at reducing airway smooth muscle growth.
Martin JG; Greenstone EA; Maghni K
Monaldi Arch Chest Dis; 2000 Aug; 55(4):311-6. PubMed ID: 11057085
[TBL] [Abstract][Full Text] [Related]
10. CD8(+) T cells characterize early smoking-related airway pathology in patients with asthma.
Ravensberg AJ; Slats AM; van Wetering S; Janssen K; van Wijngaarden S; de Jeu R; Rabe KF; Sterk PJ; Hiemstra PS
Respir Med; 2013 Jul; 107(7):959-66. PubMed ID: 23639272
[TBL] [Abstract][Full Text] [Related]
11. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.
Tomari S; Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Kawano T; Matsuo N; Kohno S
Respiration; 2008; 76(4):398-402. PubMed ID: 18689991
[TBL] [Abstract][Full Text] [Related]
12. Airway pathology in severe asthma is related to airflow obstruction but not symptom control.
Ferreira DS; Carvalho-Pinto RM; Gregório MG; Annoni R; Teles AM; Buttignol M; Araújo-Paulino BB; Katayama EH; Oliveira BL; Del Frari HS; Cukier A; Dolhnikoff M; Stelmach R; Rabe KF; Mauad T
Allergy; 2018 Mar; 73(3):635-643. PubMed ID: 28960335
[TBL] [Abstract][Full Text] [Related]
13. Modulation of bronchial inflammation: corticosteroids and other therapeutic agents.
Laitinen LA; Laitinen A
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 2):S87-90. PubMed ID: 7952601
[TBL] [Abstract][Full Text] [Related]
14. Airway remodelling in asthma and novel therapy.
Manuyakorn W; Howarth PH; Holgate ST
Asian Pac J Allergy Immunol; 2013 Mar; 31(1):3-10. PubMed ID: 23517388
[TBL] [Abstract][Full Text] [Related]
15. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Kelly MM; Chakir J; Vethanayagam D; Boulet LP; Laviolette M; Gauldie J; O'Byrne PM
Chest; 2006 Sep; 130(3):741-53. PubMed ID: 16963671
[TBL] [Abstract][Full Text] [Related]
16. Distribution of airway smooth muscle remodelling in asthma: relation to airway inflammation.
Elliot JG; Jones RL; Abramson MJ; Green FH; Mauad T; McKay KO; Bai TR; James AL
Respirology; 2015 Jan; 20(1):66-72. PubMed ID: 25257809
[TBL] [Abstract][Full Text] [Related]
17. The role of leukotrienes in airway remodeling.
Mehrotra AK; Henderson WR
Curr Mol Med; 2009 Apr; 9(3):383-91. PubMed ID: 19355919
[TBL] [Abstract][Full Text] [Related]
18. Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling.
Walters EH; Reid DW; Johns DP; Ward C
Eur Respir J; 2007 Sep; 30(3):574-88. PubMed ID: 17766634
[TBL] [Abstract][Full Text] [Related]
19. [Airway remodeling in asthma].
Zagdańska R; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2003; 71(5-6):288-95. PubMed ID: 14587437
[TBL] [Abstract][Full Text] [Related]
20. [Clinical relevance of distal airway involvement in asthma].
Torrego Fernández A; Muñoz Cano RM
Arch Bronconeumol; 2011 Apr; 47 Suppl 2():17-9. PubMed ID: 21640280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
